| Typicality: | 0.384 |
| Saliency: | 0.315 |
| for neurodegenerative diseases | 6 | transitive-object |
| for the myoc-associated poag | 3 | transitive-object |
| to eliminate the mutant myocilin proteins | 2 | purpose |
| gene → silence → therapy | 26 |
| negative | neutral | positive |
| 0.118 | 0.748 | 0.134 |
| Raw frequency | 26 |
| Normalized frequency | 0.315 |
| Modifier score | 0.500 |
| Perplexity | 43.927 |